Pen Needles Market 2020 World Analysis and Forecast Till 2026

The global pen needles market was valued at USD 1.5 billion in 2015, which is projected to grow at a CAGR of more than 13.0% during the forecast period.

According to the WHO, in 2014, 422 million people had diabetes and it is estimated that it would be the 7th leading cause of death in 2030.

Co. UK, obesity accounts for 80% to 85% chances of developing type 2 diabetes.

Short length pen needles can be easily used by everyone including overweight, children, and the patient with phobia of needles.

For instance, in 2014, Novo Nordisk made NovoFine Plus, the thinnest and shortest needle commercially available in the U.S.

It does not offer resistance while injecting and provides greater comfort as compared to other injections.

The global insulin pen needles market is estimated to witness a significant growth in forthcoming years, says TMR.

In order increase their global reach, firms are investing heavily in the research and development activities.

The firms leading in the global pen needle market are Dickinson and Company, Becton, Novo Nordisk A/S, Ypsomed Holding AG, Ultimed, Inc., Artsana S.P.A., B. Braun Melsungen, Allison Medical, Inc., Terumo Corporation, Owen Mumford, Ltd., and Htl-Strefa S.A.

As per Transparency Market Research the global market of insulin pen needles is likely to expand at a steady CAGR of 8.0% during 2017 to 2026.

Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=34937On the basis of application type, the segment of type II diabetes is foreseen to experience a strong rise as per the revenue, holding a value of more than US$ 1,000 mn by the end of forecast period.

Organizations in the medical sectors are primarily concentrating on creating therapeutic gadgets, for example, 'Timesulin', which is insulin pens that enables the patients to manage dose measurements through pumps.

Pen needles, as compared to traditional syringes and vials, provide a convenient, easier and more accurate dosage.

Such needles do not require to be pushed through the rubber vial stopper and thus tend to retain their sharpness and lubrication.

Such needles, on account of accidental strokes, possess a high risk of secondary infections, which can be reduced by the use of pen needles.

Thus, this market possesses a lucrative potential.Insulin pens are the most convenient and fastest mode of injecting drug delivery.

Pen needles are highly demanded in conjunction with growing need for insulin pens for people suffering from diabetes.

These devices used with insulin pens help in delivering the dosage of the drug to the patient.Request Exclusive Free Sample of Pen Needles Market Report @ https://dataintelo.com/request-sample/?reportId=551Insulin pens coupled with needles are considered as an improved alternative drug delivery process in comparison to syringes and vials.

Pen Needle market manufacturers have developed needles to minimize pain and help to reduce skin trauma, majorly by innovating needle length and diameter, to maintain a sufficient inner lumen was the major challenge for needle manufacturers by maintaining acceptable low injection force.

To maintain sufficient inner lumen manufacturer made thin needle walls, which reduced the needles robustness and increased chances of needles tip damage during administration, re-usage and during cap removal or handling.Pen needles are used in pen devices to deliver injectable drug in diabetes and growth hormone deficiency to maintain blood sugar level.

The World Health Organization and international diabetes federation has projected more than 50% rise in number of diabetes patients by 2045.

Also, United Nation and World Health Organization has projected more than 100% rise in geriatric population in the globe, this rise will lead the global pen needles market.Asia-Pacific pen needles market is projected to register a healthy CAGR in the forecast period 2019 to 2026.This Asia-Pacific Pen Needles Market research report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of Cardinal Health industry.

The report also recognizes and analyses the rising trends along with major drivers, challenges and opportunities in the market.

This Asia-Pacific Pen Needles Market report provides major statistics on the market status of global and regional manufacturers and is a helpful source of assistance and direction for companies and individuals interested in Healthcare industry.

Hyaluron Pen is an innovation that deposits Hyaluronic Acid Filler into the epidermal and upper dermal layers of the skin without traditional needles or injections.

28 January 2020 - The Global Pen Needles Market was valued at USD 1.5 billion in 2015, which is projected to grow at a CAGR of more than 13.0% during the forecast period.

According to the WHO, in 2014, 422 million people had diabetes and it is estimated that it would be the 7th leading cause of death in 2030.

Co. UK, obesity accounts for 80% to 85% chances of developing type 2 diabetes.

Excess abdominal fat, increases the chances of having this type of disorder.Pen needles helps in easy delivery of drug to the patient.

Short length pen needles can be easily used by everyone including overweight, children, and the patient with phobia of needles.

For instance, in 2014, Novo Nordisk made NovoFine Plus, the thinnest and shortest needle commercially available in the U.S.Pen needles when used in conjunction with insulin pens provide easy and convenient drug delivery process when compared to the traditional method of syringes and vials.

The Hyaluron Pen uses pressure technology to deposit Hyaluronic acid filler into the epidermal and upper dermal layers of the skin without using traditional needles.